| Authors: |
Liccione MF; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Scobey T; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Froggatt HM; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Pajon C; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Yount BL; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Yin Q; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Spence TN; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Walter EB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Department of Microbiology and Molecular Genetics, Duke University School of Medicine, Durham, NC, USA., Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Department of Integrative Immunology, Duke University School of Medicine, Durham, NC, USA., Cain DW; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wrapp D; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. daniel.wrapp@duke.edu. |
